Neuraxis INC
For the period ended Dec 31, 2023. Filed Apr 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 16, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| NEURAXIS, INC. | ||
| Dated: April 16, 2024 | By: | /s/ Brian Carrico |
|---|---|---|
| Brian Carrico | ||
| Chief Executive Officer | ||
| Dated: April 16, 2024 | By: | /s/ Timothy R. Henrichs |
| Timothy R. Henrichs | ||
| Chief Financial Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Brian Carrico | Chief Executive Officer and Director | April 16, 2024 |
| Brian Carrico | (Principal Executive Officer) | |
| /s/ Timothy R. Henrichs | Chief Financial Officer (Principal | April 16, 2024 |
| Timothy R. Henrichs | Financial Officer and Principal Accounting Officer) | |
| /s/ Christopher Robin Brown | Director | April 16, 2024 |
| Christopher Robin Brown | ||
| /s/ Bradley Mitch Watkins | Director | April 16, 2024 |
| Bradley Mitch Watkins | ||
| /s/ Beth Keyser | Director | April 16, 2024 |
| Beth Keyser | ||
| /s/ Kristin Ferge | Director | April 16, 2024 |
| Kristin Ferge | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.